Alx Oncology Holdings Inc. · NASDAQ:ALXO
Redmile Group, LLC's stake in Alx Oncology Holdings Inc. fell to 6.80% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Redmile Group, LLC's stake in Alx Oncology Holdings Inc. fell to 6.80%, 9,214,188 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 9,214,188
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Redmile Group, LLC | 6.80% | 9,214,188 |
| Jeremy C. Green | 6.80% | 9,214,188 |
| Redmile Biopharma Investments III, L.P. | 3.90% | 5,267,838 |
Source
Related
- Alx Oncology Holdings Inc.
- Redmile Group, LLC
- Alx Oncology Holdings Inc. shareholders
- Schedule 13G/A · Redmile Group, LLC · Aug 14, 2025
- Schedule 13D/A · venBio Global Strategic Fund, L.P. · Oct 16, 2026
- Form 4 · Lettmann Jason · Aug 18, 2026
- Form 4 · Wong Shelly · Aug 18, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026